Company Filing History:

7 out of 7

Coastside Bio Resources

patents

2 out of 2,123

Northwestern University

4. 4 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2008

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7387797 - [object Object] (2008-06-17),

2. 7335382 - Compositions and methods for the treatment and prevention of cancer (2008-02-26),

3. 7163702 - Process for isolating sea cucumber saponin Frondoside A, and immunomodulatory methods of use (2007-01-16),

4. 7144867 - Anticancer glycoside compounds (2006-12-05),

5. 6767890 - Peptides having anti-cancer and anti-inflammatory activity (2004-07-27),

6. 6541519 - Methods and compositions for treating lipoxygenase-mediated disease states (2003-04-01),

7. 6428817 - Companion animal therapeutic treat (2002-08-06),

8. 6399105 - Sea cucumber carotenoid lipid fraction products and methods of use (2002-06-04),

9. 6055936 - Sea cucumber carotenoid lipid fractions and process (2000-05-02),

10. 5989592 - Inhibition of complement pathway by sea cucumber fractions (1999-11-23),

11. 5985330 - Inhibition of angiogenesis by sea cucumber fractions (1999-11-16),

12. 5876762 - Process for obtaining medically active fractions from sea cucumbers (1999-03-02),

13. 5770205 - Tissue fractions of sea cucumber for the treatment of inflammation (1998-06-23),

Title: The Innovative Contributions of Peter Donald Collin

Introduction

Peter Donald Collin is a notable inventor based in Sunset, ME (US). He has made significant contributions to the field of cancer treatment through his innovative inventions. With a total of 13 patents, Collin's work focuses on developing new methods and compositions for combating adenocarcinoma and other related conditions.

Latest Patents

Collin's latest patents include compositions that feature isolated soft tissue and oils derived from specific sources. These inventions disclose methods for treating adenocarcinoma in subjects, which involve decreasing the proliferation of adenocarcinoma cells, inducing apoptosis, and promoting differentiation into non-cancerous cells. Additionally, he has developed methods for inhibiting the activity of 5-lipoxygenase and 12-lipoxygenase, which are crucial in managing diseases associated with excessive activity of these enzymes. His work also encompasses processes for preparing extracts that can be utilized in cancer treatment and prevention, highlighting the potential of natural sources as anti-cancer agents.

Career Highlights

Throughout his career, Collin has worked with various organizations, including Coastside Bio Resources. His innovative approach and dedication to research have positioned him as a key figure in the development of anti-cancer therapies.

Collaborations

Collin has collaborated with notable individuals in his field, including Thomas E Adrian and Peiying Yang. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Peter Donald Collin's contributions to cancer treatment through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to inspire advancements in medical research and therapy development.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com